No Data
No Data
Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Cardiol Therapeutics Says Study Shows Benefit of Cannabidiol Drug in Treating Heart Failure | TSX:CRDL, NASDAQ:CRDL
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart...
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study
Cardiol Says Pilot Study Shows CardioRx Efficacy